Detailed Information on Publication Record
2000
Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction.
HONZÍKOVÁ, Nataša, Bořivoj SEMRÁD, Bohumil FIŠER and Růžena LÁBROVÁBasic information
Original name
Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction.
Name in Czech
Citlivost baroreflexu stanovená spektrální metodou a variabilita tepové frekvence, mortalita pacientů dva roky po infartu myokardu
Authors
HONZÍKOVÁ, Nataša (203 Czech Republic, guarantor), Bořivoj SEMRÁD (203 Czech Republic), Bohumil FIŠER (203 Czech Republic) and Růžena LÁBROVÁ (203 Czech Republic)
Edition
Physiological Research, Praha, Institute of Physiology Academy of Sci. 2000, 0862-8408
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30105 Physiology
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.366
RIV identification code
RIV/00216224:14110/00:00002701
Organization unit
Faculty of Medicine
UT WoS
000166656600003
Keywords in English
Baroreflex sensitivity; spectral analysis; myocardial infarction; cardiac death; risk stratification.
Tags
Změněno: 17/6/2009 14:44, prof. MUDr. Nataša Honzíková, CSc.
V originále
The impact of an autonomic dysfunction (AD) on mortality in patients after myocardial infarction was evaluated. We examined 162 patients (20 died in two years after myocardial infarction). Baroreflex sensitivity BRS<3ms/mmHg (spectral analysis of spontaneous fluctuations of systolic blood pressure and cardiac intervals) and/or SDNN index<30ms (from 24-hour ECG recording) were taken as markers of AD. The risk stratification was performed according to the number of following standard risk factors (SRF): ejection fraction;40%, positive late potentials and presence of ventricular extrasystoles;10/hour. In 92 patients without SRF, there was no difference in mortality between patients with AD (4%) and without AD (4.5%). In 6 patients with three SRF, mortality was 66.6%. Of 64 patients with one or two SRF, 32 had AD. Mortality was 6.25% in patients without AD and 31.2% in those with AD (p<0.025). AD increased five times the two years mortality in patients with moderate risks.
In Czech
Vliv autonomní dysfunkce na mortalitu pacientů po infarktu myokardu byla studována u 162 pacientů (20 zemřelo během dvou let po IM).Riziková stratifikace byla hodnocena pro autonomní dysfunkci(citlivost baroreflexu, variabilitu tepové frekvence) a pro ejekční frakci, pozdní potenciály a počet extrasystol za hodinu. Autonomní dysfunkce zvýšila mortalitu šestkrát.